David Hamisi Mvunta

Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target

Ryoichi Asaka, Tsutomu Miyamoto, Yasushi Yamada et al. · Laboratory Investigation · 2015 · 93 citations · Full text

Medicine, Molecular Biology, Oncology +15

SIRT1 Regulates the Chemoresistance and Invasiveness of Ovarian Carcinoma Cells

David Hamisi Mvunta, Tsutomu Miyamoto, Ryoichi Asaka et al. · Translational Oncology · 2017 · 47 citations · Full text

Medicine, Molecular Biology, Oncology +17

Overexpression of SIRT1 is Associated With Poor Outcomes in Patients With Ovarian Carcinoma

David Hamisi Mvunta, Tsutomu Miyamoto, Ryoichi Asaka et al. · Applied immunohistochemistry & molecular morphology · 2016 · 44 citations

Medicine, Gynecology, Oncology +13

Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells

Tsutomu Miyamoto, Hiroyasu Kashima, Yasushi Yamada et al. · PLoS ONE · 2016 · 37 citations · Full text

Medicine, Molecular Biology, Oncology +11

Quality of life among cervical cancer patients following completion of chemoradiotherapy at Ocean Road Cancer Institute (ORCI) in Tanzania

David Hamisi Mvunta, Furaha August, Nazima Dharsee et al. · BMC Women s Health · 2022 · 21 citations · Full text

Medicine, Oncology, Radiation Oncology +13